Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(75.0%)
N/A
1(25.0%)
4Total
Phase 3(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04290572Phase 3Unknown

Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts

Role: lead

NCT03585140Not ApplicableCompleted

Low Glycemic Index and Load Diet for the Treatment of Acne

Role: lead

NCT03585179Phase 3Unknown

Oral and Topical Tranexamic Acid for the Treatment of Melasma

Role: lead

NCT02823236Phase 3Unknown

Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars

Role: lead

All 4 trials loaded